Pine Labs Acquires Qfix to Enhance Radiotherapy Solutions

Pine Labs has acquired Qfix for an undisclosed amount.

Qfix is an innovative medical device company focused on discovering, developing, and commercializing technology-driven solutions for radiotherapy patient positioning in cancer treatment, known for its deep engagement with medical professionals and commitment to enhancing precision and patient comfort.

Qfix's product portfolio includes pioneering solutions such as Aquaplast RT™, the original low-temperature thermoplastic, and Fibreplast™, a Kevlar® reinforced version, both widely used globally for creating rigid immobilization masks and shells.

Additionally, the revolutionary kVue™ IGRT Couch Top offers advanced customization for individual patient needs across various disease sites, providing a complete and highly advanced system for both kV imaging and MV treatment.

This acquisition explicitly marks a strategic expansion for Pine Labs, signaling its entry into the highly specialized and critical field of advanced medical technology.

The integration of Qfix's profound expertise and intellectual property in radiotherapy patient positioning is anticipated to drive substantial innovation within this vital sector, meeting the accelerating global demand for precise and effective cancer treatment solutions.

Expected synergies from this acquisition will likely focus on leveraging Pine Labs' substantial operational and financial resources to significantly accelerate Qfix's research, development, and broader market reach, particularly as it expands under its established CQ Medical brand.

The combined entity aims to advance patient care globally through continued technological innovation in medical devices, thereby expanding the impact and accessibility of precise positioning solutions for cancer patients worldwide.